Cargando…

Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review

BACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifaceted condition that affects most body systems. There is currently no known diagnostic biomarker; instead, diagnosis is dependent on application of symptom-based case criteria following exclusion of any other potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maksoud, Rebekah, Magawa, Chandi, Eaton-Fitch, Natalie, Thapaliya, Kiran, Marshall-Gradisnik, Sonya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206551/ https://www.ncbi.nlm.nih.gov/pubmed/37226227 http://dx.doi.org/10.1186/s12916-023-02893-9

Ejemplares similares

A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Taccori, Asher, et al.
Publicado: (2023)

A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques
por: Maksoud, Rebekah, et al.
Publicado: (2020)

A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)
por: Corbitt, Matthew, et al.
Publicado: (2019)

A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID)
por: Huth, Teilah Kathryn, et al.
Publicado: (2020)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients
por: Thapaliya, Kiran, et al.
Publicado: (2023)

Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study
por: Balinas, Cassandra, et al.
Publicado: (2021)

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Correction to: A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study
por: Słomko, Joanna, et al.
Publicado: (2019)

Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2021)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
por: Deumer, Undine-Sophie, et al.
Publicado: (2021)

Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Eaton-Fitch, Natalie, et al.
Publicado: (2019)

Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Du Preez, Stanley, et al.
Publicado: (2023)

How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
por: Nacul, Luis, et al.
Publicado: (2020)

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Günther, Oliver P., et al.
Publicado: (2018)

The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Glassford, Julian A. G.
Publicado: (2017)

The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
por: König, Rahel S., et al.
Publicado: (2022)

Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Rasa, Santa, et al.
Publicado: (2018)

Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
por: Mitchell, William M
Publicado: (2016)

Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Cliff, Jacqueline M., et al.
Publicado: (2019)

Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Lim, Eun-Jin, et al.
Publicado: (2020)

Erratum: The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
Publicado: (2022)

A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life
por: Weigel, Breanna, et al.
Publicado: (2021)

Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Gravelsina, Sabine, et al.
Publicado: (2021)

Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Eaton-Fitch, Natalie, et al.
Publicado: (2022)

Initiating Care of a Patient With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Lapp, Charles W.
Publicado: (2019)

Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases
por: Comerford, Barbara B., et al.
Publicado: (2019)

Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: de Vega, Wilfred C., et al.
Publicado: (2017)

Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Wirth, Klaus J., et al.
Publicado: (2021)

Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Li, Xia, et al.
Publicado: (2021)

Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Moore, Geoffrey E., et al.
Publicado: (2023)

Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: van Campen, C. (Linda) M.C., et al.
Publicado: (2023)

Identification of transient receptor potential melastatin 3 proteotypic peptides employing an efficient membrane protein extraction method for natural killer cells
por: Magawa, Chandi T., et al.
Publicado: (2022)

Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Sasso, Etianne Martini, et al.
Publicado: (2022)

Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP(2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Du Preez, Stanley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73tdtgbst0c0tlfcmm2551fdch